Spatial profiling reveals association between WNT pathway activation and T-cell exclusion in acquired resistance of synovial sarcoma to NY-ESO-1 transgenic T-cell therapy

BACKGROUND: Genetically engineered T-cell immunotherapies for adoptive cell transfer (ACT) have emerged as a promising form of cancer treatment, but many of these patients develop recurrent disease. Furthermore, delineating mechanisms of resistance may be challenging since the analysis of bulk tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Campbell, Katie M, Thaker, Maneesha, Medina, Egmidio, Kalbasi, Anusha, Singh, Arun, Ribas, Antoni, Nowicki, Theodore Scott
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915285/
https://www.ncbi.nlm.nih.gov/pubmed/35264439
http://dx.doi.org/10.1136/jitc-2021-004190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915285/
https://www.ncbi.nlm.nih.gov/pubmed/35264439
http://dx.doi.org/10.1136/jitc-2021-004190

Ejemplares similares